In clinic, monocytes are found to express NKG2D ligands in patients with several types of cancer including glioblastoma, breast cancer, prostate cancer, and hepatocellular carcinomas,127 suggesting it may represent a common mechanism of immune evasion. Here, KLRK1 is linked to cancer.